Voriconazole therapeutic drug monitoring is not consistently recommended due to its high interpatients and intrapatients variability. Here, we aimed to describe our experience with voriconazole for treatment and prophylaxis of invasive fungal infections, in paediatric patients. A fully validated HPLC-MS method was used to quantify voriconazole concentration in plasma, at the end of dosing interval. A high interindividual variability was shown. We enrolled 237 children, 83 receiving intravenous and 154 oral voriconazole. A positive correlation between drug dose and drug plasma exposure was observed. Considering intravenous route, patients with higher serum creatinine had higher voriconazole concentrations; a positive correlation was found among drug exposure and age. Moreover gender significantly influenced drug levels: males had higher median drug concentrations than females (p<0.001). Close voriconazole pharmacokinetics monitoring should help individualize antifungal therapy for children.

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children

ALLEGRA, SARAH
First
;
FATIGUSO, GIOVANNA;DE FRANCIA, SILVIA;FAVATA, FABIO;PIRRO, Elisa;CARCIERI, CHIARA;DE NICOLO', AMEDEO;CUSATO, JESSICA;DI PERRI, Giovanni;D'AVOLIO, ANTONIO
Last
2018

Abstract

Voriconazole therapeutic drug monitoring is not consistently recommended due to its high interpatients and intrapatients variability. Here, we aimed to describe our experience with voriconazole for treatment and prophylaxis of invasive fungal infections, in paediatric patients. A fully validated HPLC-MS method was used to quantify voriconazole concentration in plasma, at the end of dosing interval. A high interindividual variability was shown. We enrolled 237 children, 83 receiving intravenous and 154 oral voriconazole. A positive correlation between drug dose and drug plasma exposure was observed. Considering intravenous route, patients with higher serum creatinine had higher voriconazole concentrations; a positive correlation was found among drug exposure and age. Moreover gender significantly influenced drug levels: males had higher median drug concentrations than females (p<0.001). Close voriconazole pharmacokinetics monitoring should help individualize antifungal therapy for children.
84
1
197
203
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736853/
Allegra, Sarah; Fatiguso, Giovanna; De Francia, Silvia; Favata, Fabio; Pirro, Elisa; Carcieri, Chiara; De Nicolò, Amedeo; Cusato, Jessica; Di Perri, Giovanni; D'Avolio, Antonio
File in questo prodotto:
File Dimensione Formato  
Allegra_et_al-2017-British_Journal_of_Clinical_Pharmacology.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 297.94 kB
Formato Adobe PDF
297.94 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
De Francia_1_315438_Therapeutic drug.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 282.25 kB
Formato Adobe PDF
282.25 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1650809
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 26
social impact